Zolgensma savings card: as little as $0 an infusion with commercial insurance

How to pay the least

Ask for the cash price

Zolgensma

Zolgensma is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Ask your pharmacy for Zolgensma’s cash price, and one or two other pharmacies too.
Zolgensma’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameZolgensma

Authorized genericonasemnogene abeparvovec-xioi

Regular genericonasemnogene abeparvovec-xioi

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Zolgensma?

The original

–

Brand nameThe maker’s card

ZOLGENSMA CopayAssist Program

Savings card from Novartis

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 an infusion

Or call 1-855-441-4363.

In the maker’s words

“Eligible, privately insured patients may pay as little as $0 for ZOLGENSMA…”

From the maker’s offer on zolgensma-hcp.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Zolgensma itself, from the same company, sold without the brand name, and usually for less. For now Zolgensma is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Zolgensma is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Spinal muscular atrophy (SMA)

What the FDA label says

ZOLGENSMA is an adeno-associated virus (AAV) vector-based gene therapy indicated for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy (SMA) with bi-allelic mutations in the survival motor neuron 1 (SMN1) gene.

Limitations of Use

The safety and effectiveness of repeat administration of ZOLGENSMA have not been evaluated.
The use of ZOLGENSMA in patients with advanced SMA (e.g., complete paralysis of limbs, permanent ventilator dependence) has not been evaluated.

Source: the FDA label for Zolgensma (Novartis Innovative Technologies Inc.), June 16, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/zolgensma/